CervoMed Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 2.51 million compared to USD 0.534336 million a year ago. Basic loss per share from continuing operations was USD 0.41 compared to USD 1.03 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.5 USD | -2.33% |
|
-9.46% | +103.15% |
Jul. 01 | CervoMed Inc.(NasdaqCM:CRVO) added to Russell Small Cap Completeness Index | CI |
Jul. 01 | CervoMed Inc.(NasdaqCM:CRVO) added to Russell Microcap Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.15% | 128M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- CRVO Stock
- News CervoMed Inc.
- CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024